BLOOD LACTATE DEHYDROGENASE DECREASED side effect
What is BLOOD LACTATE DEHYDROGENASE DECREASED ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
BLOOD LACTATE DEHYDROGENASE DECREASED and Recently Reported Side Effects
BLOOD LACTATE DEHYDROGENASE DECREASED and 15 most Active Side Effect polls
BLOOD LACTATE DEHYDROGENASE DECREASED and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with BLOOD LACTATE DEHYDROGENASE DECREASED
HYCAMTIN ITRIZOLE MUCODYNE NATALIZUMAB PROGRAF TRISENOX VELCADE ZOMETANatalizumab Side Effects Report #5466884-3
Physician from GERMANY reported NATALIZUMAB problem on Sept 04, 2007. Female patient, 44 years of age, weighting 143.3 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase decreased, condition aggravated, coordination abnormal, csf cell count increased, csf glucose increased, csf protein increased, iiird nerve paresis, leukocytosis, meningism, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with GABAPENTIN, ALPRAZOLAM, OMEPRAZOLE, FENTONYL PLASTER, FEMINON. Patient was hospitalized. Patient recovered.
Zometa Side Effects Report #5776427-2
ZOMETA problem was reported by a Physician from JAPAN on June 03, 2008. Female patient, weighting 92.59 lb, was diagnosed with metastases to bone, anaemia and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase decreased, haematocrit decreased, haemoglobin decreased, impaired healing, jaw disorder, osteonecrosis, periodontal disease, red blood cell count decreased, sequestrectomy, . ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with FEMARA, MS CONTIN, GLYSENNID, LAXOBERON, FERROMIA, NAVELBINE, XELODA, ENDOXAN. Patient recovered.
Prograf Side Effects Report #5492842-9
Physician from AUSTRALIA reported PROGRAF problem on Oct 05, 2007. Male patient, 39 years of age, was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in skin, blood lactate dehydrogenase decreased, blood lactate dehydrogenase increased, colonic polyp, diarrhoea, disease progression, hepatic function abnormal, hepatosplenomegaly, . PROGRAF dosage: unknown. During the same period patient was treated with CYCLOSPORINE, PREDNISOLONE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, ETANERCEPT. Patient died.
Zometa Side Effects Report #5758908-0
ZOMETA problem was reported by a Physician from JAPAN on May 28, 2008. Female patient, weighting 92.59 lb, was diagnosed with metastases to bone, anaemia and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase decreased, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased, impaired healing, jaw disorder, osteonecrosis, periodontal disease, . ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with FEMARA, MS CONTIN, GLYSENNID, LAXOBERON, FERROMIA, NAVELBINE, XELODA, ENDOXAN. Patient recovered.
Mucodyne Side Effects Report #5657370-6
Physician from JAPAN reported MUCODYNE problem on Feb 28, 2008. Female patient, 78 years of age, was diagnosed with urticaria and was treated with MUCODYNE. After drug was administered, patient experienced the following problems/side effects: blood creatinine decreased, blood glucose increased, blood lactate dehydrogenase decreased, cheilitis, dermatitis exfoliative, feeling hot, lymphocyte count decreased, neutrophil count increased, . MUCODYNE dosage: unknown. During the same period patient was treated with ONEALFA, BONALON, ZADITEN, MUCOSTA, ALESION. Patient recovered.
Itrizole Side Effects Report #5570940-9
ITRIZOLE problem was reported by a Physician from JAPAN on Dec 10, 2007. Male patient, weighting 119.0 lb, was diagnosed with prophylaxis and was treated with ITRIZOLE. After drug was administered, patient experienced the following problems/side effects: blood calcium increased, blood creatine increased, blood lactate dehydrogenase decreased, blood potassium decreased, disease progression, electrolyte imbalance, haemoglobin decreased, intercostal neuralgia, . ITRIZOLE dosage: unknown. During the same period patient was treated with VELCADE. Patient died on 09/01/2007.
Velcade Side Effects Report #5572371-4
Physician from JAPAN reported VELCADE problem on Dec 10, 2007. Male patient, 59 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma, prophylaxis and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood calcium increased, blood creatinine increased, blood lactate dehydrogenase decreased, blood potassium decreased, blood sodium decreased, c-reactive protein increased, diarrhoea, disease progression, electrolyte imbalance, . VELCADE dosage: 1.70 MG, INTRAVENOUS;2.00 MG, INTRAVENOUS 1.50 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, LOPERAMIDE, AMARYL, PELTAZON, ZOLPIDEM TARTRATE. Patient died on 09/01/2007.
Hycamtin Side Effects Report #5465768-4
HYCAMTIN problem was reported by a Consumer or non-health professional from JAPAN on Sept 18, 2007. Male patient, 61 years of age, was treated with HYCAMTIN. After drug was administered, patient experienced the following problems/side effects: alopecia, anorexia, blood lactate dehydrogenase decreased, blood magnesium decreased, blood magnesium increased, blood phosphorus, blood phosphorus increased, blood potassium decreased, blood sodium decreased, . HYCAMTIN dosage: .95MG PER DAY. Patient recovered.
Hycamtin Side Effects Report #5411221-3
Consumer or non-health professional from JAPAN reported HYCAMTIN problem on Aug 02, 2007. Male patient, 61 years of age, was treated with HYCAMTIN. After drug was administered, patient experienced the following problems/side effects: alopecia, anorexia, blood lactate dehydrogenase decreased, blood magnesium decreased, blood magnesium increased, blood phosphorus, blood phosphorus increased, blood potassium decreased, blood sodium decreased, . HYCAMTIN dosage: .95MG PER DAY. Patient recovered.
Hycamtin Side Effects Report #5400437-8
HYCAMTIN problem was reported by a Consumer or non-health professional from JAPAN on July 20, 2007. Male patient, 61 years of age, was treated with HYCAMTIN. After drug was administered, patient experienced the following problems/side effects: alopecia, anorexia, blood lactate dehydrogenase decreased, blood magnesium decreased, blood magnesium increased, blood phosphorus, blood phosphorus increased, blood potassium decreased, blood sodium decreased, . HYCAMTIN dosage: .95MG PER DAY. Patient recovered.
Hycamtin Side Effects Report #5400437-8
Consumer or non-health professional from JAPAN reported HYCAMTIN problem on July 20, 2007. Male patient, 61 years of age, was treated with HYCAMTIN. After drug was administered, patient experienced the following problems/side effects: alopecia, anorexia, blood lactate dehydrogenase decreased, blood magnesium decreased, blood magnesium increased, blood phosphorus, blood phosphorus increased, blood potassium decreased, blood sodium decreased, . HYCAMTIN dosage: .95MG PER DAY. Patient recovered.
Mucodyne Side Effects Report #5742264-8
MUCODYNE problem was reported by a Physician from JAPAN on May 12, 2008. Female patient, 78 years of age, was diagnosed with urticaria and was treated with MUCODYNE. After drug was administered, patient experienced the following problems/side effects: blood creatinine decreased, blood glucose increased, blood lactate dehydrogenase decreased, cheilitis, dermatitis exfoliative, feeling hot, lymphocyte count decreased, neutrophil count increased, . MUCODYNE dosage: unknown. During the same period patient was treated with ONEALFA, BONALON, ZADITEN, MUCOSTA, ALESION. Patient recovered.
Mucodyne Side Effects Report #5703694-3
Physician from JAPAN reported MUCODYNE problem on Apr 07, 2008. Female patient, 78 years of age, was diagnosed with urticaria and was treated with MUCODYNE. After drug was administered, patient experienced the following problems/side effects: blood creatinine decreased, blood glucose increased, blood lactate dehydrogenase decreased, cheilitis, dermatitis exfoliative, feeling hot, lymphocyte count decreased, neutrophil count increased, . MUCODYNE dosage: unknown. During the same period patient was treated with ONEALFA, BONALON, ZADITEN, MUCOSTA, ALESION. Patient recovered.
Trisenox Side Effects Report #5336511-4
TRISENOX problem was reported by a Physician from JAPAN on May 14, 2007. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with TRISENOX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, electrocardiogram qt prolonged, hepatic function abnormal, protein total decreased, rash, white blood cell count decreased, . TRISENOX dosage: 7.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ELECTROLYTE. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5260932-1
Physician from JAPAN reported TRISENOX problem on Feb 20, 2007. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with TRISENOX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, blood urea decreased, electrocardiogram qt corrected interval prolonged, hepatic function abnormal, protein total decreased, rash, white blood cell count decreased, . TRISENOX dosage: 7.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ELECTROLYTE. Patient was hospitalized. Patient recovered.